Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 14/20 | 0.55 |
| ▸ | PPARA | Q07869 | 9/20 | 0.55 |
| ▸ | PPARD | Q03181 | 8/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.46 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | BAD | Q92934 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3180559 | 0.80 | PPARG (0.65) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL3159492 | 0.76 | PPARG (0.61) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL4237875 | 0.76 | PPARA (0.52) | PPARGPPARAPPARDMCL1BAD | |
| SCHEMBL5011220 | 0.75 | PPARG (0.59) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL5009245 | 0.74 | PPARG (0.52) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL5009209 | 0.73 | PPARG (0.54) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL5009191 | 0.73 | PPARG (0.54) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL5011262 | 0.72 | PPARG (0.53) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL5006765 | 0.72 | PPARG (0.56) | PPARGPPARAPPARDMCL1NR1H2 | |
| SCHEMBL15157114 | 0.72 | HTR2C (0.57) | PPARGPPARAPPARDHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7449478-B2 | Indole compounds | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2008-11-11 | — | — | US | disclosed |
| US-7449478-B2 | Indole compounds | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2008-11-11 | — | — | US | disclosed |
| US-7449478-B2 | Indole compounds | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2008-11-11 | — | — | US | disclosed |
| US-20050124675-A1 | Indole compounds | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2005-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050124675-A1 | Indole compounds | PPARG, PPARD, PPARA | PPARG 1/4885PPARA 3/4885PPARD 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.